WB

William B. Stilley

North America, Virginia, United States, Charlottesville

Description

William B. Stilley has served as our Chief Executive Officer since December 2010. Prior to joining Adial Pharmaceuticals, he was the Vice Pr...

Investor Profile

William B. Stilley has made 1 investments, with 0 in the past 12 months and 0% as lead.

Stage Focus

  • Seed (100%)

Country Focus

  • United States (100%)

Industry Focus

  • Biotechnology
  • Health Care
  • Medical Device
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does William B. Stilley frequently co-invest with?

i.Lab at UVA
North America, Virginia, United States, Charlottesville
Co-Investments: 1
Center for Innovative Technology
North America, Virginia, United States, Herndon
Co-Investments: 1
Afton Scientific
North America, Virginia, United States, Charlottesville
Co-Investments: 1
FundRx
North America, New York, United States, New York
Co-Investments: 1
Charlottesville Angel Network
North America, Virginia, United States, Charlottesville
Co-Investments: 1
Abstract Ventures
North America, California, United States, San Francisco
Co-Investments: 1
AC
North America, Georgia, United States, Waycross
Co-Investments: 1
Kima Ventures
Europe, Ile-de-France, France, Paris
Co-Investments: 1
Alumni Ventures
North America, New Hampshire, United States, Manchester
Co-Investments: 1
Founders Fund
North America, California, United States, San Francisco
Co-Investments: 1

Which angels does William B. Stilley often collaborate with?

BS
North America, United States
Shared Deals: 1
MG
North America, Florida, United States, Vero Beach
Shared Deals: 1

What are some of recent deals done by William B. Stilley?

Contraline

Charlottesville, Virginia, United States

Contraline is developing the first long-lasting, non-hormonal, reversible contraceptive for men

BiotechnologyHealth CareMedical Device
SeedSep 18, 2018
Amount Raised: $3,000,000